The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

Leandro Boer, MD, PhD, VP, US general medicines, Amgen, discusses new real-world data showing that most high-risk ...

What was once considered a competitive advantage for forward-thinking commercial teams has now become essential for success ...

President Trump announced a plan to reduce prescription drug prices by implementing a most-favored-nation policy with the ...

The latest Q&A installment in Pharm Exec's earned media series details key strategies for leveraging breaking news at ...

Weight-loss and diabetes drugs dominated pharmaceutical spending last year, according to a new report by the American Society ...

The Hardest Job in Biopharma? The Vice President of Market Access ...

Stricter regulations on a fragmented media landscape is forcing the industry to rethink marketing.

Armando Castro, partner, emerging companies, venture capital, Lowenstein Sandler, explains how repurposing GLP-1s and ...

The Hardest Job in Biopharma? The Vice President of Market Access ...

The order pushes drug companies to reduce drug prices in the United States to fall in line with other countries around the ...

A successful M&A outcome is contingent upon a deep understanding of the regulatory and scientific fundamentals that underpin ...